TRDA – entrada therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Entrada Therapeutics: Soft Q3 Earnings, But Builds Momentum Toward 2026 Readouts [Seeking Alpha]
Entrada Therapeutics (NASDAQ:TRDA) was given a new $13.00 price target on by analysts at Roth Capital.
Entrada Therapeutics Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
Entrada Therapeutics Reports Third Quarter 2025 Financial Results
Form EFFECT Entrada Therapeutics,
Form SCHEDULE 13G Entrada Therapeutics, Filed by: TCG Crossover GP I, LLC
Form 4 Entrada Therapeutics, For: Nov 21 Filed by: WENTWORTH KORY JAMES
Form 4 Entrada Therapeutics, For: Nov 20 Filed by: BAKER BROS. ADVISORS LP
Form 144 Entrada Therapeutics, Filed by: WENTWORTH KORY JAMES
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.